by Mohit Kumar Jolly, The Conversation
Metastasis, the spread of cancer cells from a primary tumour to different organs, is responsible for more than 90% of deaths due to cancer. Current treatments such as chemotherapy or radiotherapy are effective against primary tumours, but they cannot stop or kill the circulating cancer cells in the bloodstream. This means that understanding how cancer cells start to metastasise is crucial for developing new anti-metastasis therapies.
Now, researchers at Rice University (including myself) have deciphered how a network of genes allows cancer cells to "decide" when to metastasise, thus opening up new therapeutic avenues.
Cancer cells in a primary tumour are usually fixed and immovable (sessile). However, if some of the cancer cells from the primary tumour start to invade neighbouring healthy tissue and enter the bloodstream to spread to different organs, it is bad news for the patient, because each one of these circulating cancer cells is capable of giving rise to a new tumour elsewhere in the body. Every cancer cell in the primary tumour either stays bound to its neighbours or metastasises. This decision is taken by a network of genes that functions as a switch, allowing each cell to either be "on" (migrating) or "off" (not migrating).
We discovered that this genetic switch also allows for a third choice that lies somewhere between "on" and "off": cancer cells can move collectively, or migrate while still bound to their neighbours. These findings are crucial, because they underline a striking similarity in the collective cell migration of cancer cells and the kind of cell migration seen during wound healing.
This means that anti-metastasis strategies must be developed while keeping in mind that they do not inhibit wound healing. Even more care should be taken as the wound-healing drugs should not promote metastasis, in case a tumour is present.
Switch to spread
After circulating, cancer cells exit the bloodstream to settle at a distant organ. They switch back to being sessile and start growing another tumour at that organ. We show that moving collectively is advantageous to the cancer cells, because it is much easier for collectively moving cells rather than individually moving cells to switch back to a sessile state at a distant organ and start growing another tumour.
The metastasis "decision switch" consists of two specialised pairs of proteins, namely (SNAIL and microRNA34) and (ZEB and microRNA200). Both pairs are "mutually inhibitory", with each partner in a pair inhibiting the production of the other. Imagine two people, A and B, who hate each other and refuse to attend a party where the other is present. Therefore, usually, in such pairs, one gets only two possibilities: either only A attends or only B attends – the concentration of the first protein is high and the second low, or vice-versa. In sessile cancer cells, the concentration of microRNAs is higher and that of ZEB and SNAIL low, and vice-versa for individually migrating cells.
The simple explanation then would be that these mutually inhibitory pairs behave as a switch, allowing for an "on" and an "off" state. However, our study shows that they actually behave as two switches, allowing for three possibilities. This they do because depending on the strength of inhibition (or degree of hatred) and other regulations (such as self-activation), such pairs can behave differently from being a usual two-way switch.
SNAIL and microRNA34 inhibit each other weakly. As a result, they both can be present at the same time (without driving any of them to extinction), with their exact amounts being decided by interactions with other genes – allowing three cases – A present, B absent; B present, A absent; and both A and B present under certain conditions.
It is the dance of these two pairs of proteins which allows cancer cells to have a three-way switch, rather than the previously thought two-way switch. Since this decision-making switch is common across cancers that originate in breast, prostate, colon, or pancreas, the results are potentially of importance for more than 60% of all cancer patients.
This process is remarkably similar to the body's repair mechanism, where group of skin cells move to close a surface wound. Their collective movement allows the wound to be healed. Using this strategy often means they gain the best of both worlds – cell-cell cooperation to spread and uncontrolled growth. Knowing this process can enable us to better tackle metastasis, one of the most critical areas of cancer research and future treatment.
Explore further: Physicists decode decision circuit of cancer metastasis
This story is published courtesy of The Conversation (under Creative Commons-Attribution/No derivatives).
Medical Xpress on facebook
Related Stories
Physicists decode decision circuit of cancer metastasis
Oct 24, 2013
Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and invade other parts of the body. The study found ...
New breast cancer stem cell findings explain how cancer spreads
Jan 14, 2014
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes ...
New prostate cancer drugs may not be targeting root cause of disease, scientists warn
Jan 27, 2014
(Medical Xpress)—New drugs being developed for the treatment of prostate cancer may not be targeting the root cause of the disease, according to research published today (Friday, 24 January 2014) in Cell De ...
Research discovers non–toxic cancer treatment
Jan 23, 2014
(Medical Xpress)—A University of Queensland researcher is developing a "Trojan horse" non-toxic treatment for human breast cancer.
Researchers discover protein that may control the spread of cancer
Feb 26, 2013
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at ...
Recommended for you
Smoking linked with increased risk of most common type of breast cancer
7 hours ago
Young women who smoke and have been smoking a pack a day for a decade or more have a significantly increased risk of developing the most common type of breast cancer. That is the finding of an analysis published ...
Clues to cancer pathogenesis found in cell-conditioned media
7 hours ago
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue. By growing PEL cells ...
Study involving twin sisters provides clues for battling aggressive cancers
18 hours ago
Analyzing the genomes of twin 3-year-old sisters – one healthy and one with aggressive leukemia – led an international team of researchers to identify a novel molecular target that could become a way ...
Gaps exist in patient-centered quality of CRC care at VA
Feb 08, 2014
(HealthDay)—Patient-reported quality assessment measures reveal substantial gaps in patient-centered quality of colorectal cancer care, according to a study published online Feb 3 in the Journal of Clinical On ...
Synthesised sponge chemical shows promise for cancer
Feb 07, 2014
A promising compound for cancer treatment has been synthesised in a laboratory by an RMIT University researcher conducting PhD research.
Power lines don't raise risk of leukaemia in children
Feb 07, 2014
(Medical Xpress)—Children who live near overhead power lines in early life do not have a greater risk of developing childhood leukaemia, researchers from the Childhood Cancer Research Group at the University ...
User comments
© Medical Xpress 2011-2014, Science X network
by Mohit Kumar Jolly, The Conversation
Metastasis, the spread of cancer cells from a primary tumour to different organs, is responsible for more than 90% of deaths due to cancer. Current treatments such as chemotherapy or radiotherapy are effective against primary tumours, but they cannot stop or kill the circulating cancer cells in the bloodstream. This means that understanding how cancer cells start to metastasise is crucial for developing new anti-metastasis therapies.
Now, researchers at Rice University (including myself) have deciphered how a network of genes allows cancer cells to "decide" when to metastasise, thus opening up new therapeutic avenues.
Cancer cells in a primary tumour are usually fixed and immovable (sessile). However, if some of the cancer cells from the primary tumour start to invade neighbouring healthy tissue and enter the bloodstream to spread to different organs, it is bad news for the patient, because each one of these circulating cancer cells is capable of giving rise to a new tumour elsewhere in the body. Every cancer cell in the primary tumour either stays bound to its neighbours or metastasises. This decision is taken by a network of genes that functions as a switch, allowing each cell to either be "on" (migrating) or "off" (not migrating).
We discovered that this genetic switch also allows for a third choice that lies somewhere between "on" and "off": cancer cells can move collectively, or migrate while still bound to their neighbours. These findings are crucial, because they underline a striking similarity in the collective cell migration of cancer cells and the kind of cell migration seen during wound healing.
This means that anti-metastasis strategies must be developed while keeping in mind that they do not inhibit wound healing. Even more care should be taken as the wound-healing drugs should not promote metastasis, in case a tumour is present.
Switch to spread
After circulating, cancer cells exit the bloodstream to settle at a distant organ. They switch back to being sessile and start growing another tumour at that organ. We show that moving collectively is advantageous to the cancer cells, because it is much easier for collectively moving cells rather than individually moving cells to switch back to a sessile state at a distant organ and start growing another tumour.
The metastasis "decision switch" consists of two specialised pairs of proteins, namely (SNAIL and microRNA34) and (ZEB and microRNA200). Both pairs are "mutually inhibitory", with each partner in a pair inhibiting the production of the other. Imagine two people, A and B, who hate each other and refuse to attend a party where the other is present. Therefore, usually, in such pairs, one gets only two possibilities: either only A attends or only B attends – the concentration of the first protein is high and the second low, or vice-versa. In sessile cancer cells, the concentration of microRNAs is higher and that of ZEB and SNAIL low, and vice-versa for individually migrating cells.
The simple explanation then would be that these mutually inhibitory pairs behave as a switch, allowing for an "on" and an "off" state. However, our study shows that they actually behave as two switches, allowing for three possibilities. This they do because depending on the strength of inhibition (or degree of hatred) and other regulations (such as self-activation), such pairs can behave differently from being a usual two-way switch.
SNAIL and microRNA34 inhibit each other weakly. As a result, they both can be present at the same time (without driving any of them to extinction), with their exact amounts being decided by interactions with other genes – allowing three cases – A present, B absent; B present, A absent; and both A and B present under certain conditions.
It is the dance of these two pairs of proteins which allows cancer cells to have a three-way switch, rather than the previously thought two-way switch. Since this decision-making switch is common across cancers that originate in breast, prostate, colon, or pancreas, the results are potentially of importance for more than 60% of all cancer patients.
This process is remarkably similar to the body's repair mechanism, where group of skin cells move to close a surface wound. Their collective movement allows the wound to be healed. Using this strategy often means they gain the best of both worlds – cell-cell cooperation to spread and uncontrolled growth. Knowing this process can enable us to better tackle metastasis, one of the most critical areas of cancer research and future treatment.
Explore further: Physicists decode decision circuit of cancer metastasis
This story is published courtesy of The Conversation (under Creative Commons-Attribution/No derivatives).
Medical Xpress on facebook
Related Stories
Physicists decode decision circuit of cancer metastasis
Oct 24, 2013
Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and invade other parts of the body. The study found ...
New breast cancer stem cell findings explain how cancer spreads
Jan 14, 2014
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes ...
New prostate cancer drugs may not be targeting root cause of disease, scientists warn
Jan 27, 2014
(Medical Xpress)—New drugs being developed for the treatment of prostate cancer may not be targeting the root cause of the disease, according to research published today (Friday, 24 January 2014) in Cell De ...
Research discovers non–toxic cancer treatment
Jan 23, 2014
(Medical Xpress)—A University of Queensland researcher is developing a "Trojan horse" non-toxic treatment for human breast cancer.
Researchers discover protein that may control the spread of cancer
Feb 26, 2013
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at ...
Recommended for you
Smoking linked with increased risk of most common type of breast cancer
7 hours ago
Young women who smoke and have been smoking a pack a day for a decade or more have a significantly increased risk of developing the most common type of breast cancer. That is the finding of an analysis published ...
Clues to cancer pathogenesis found in cell-conditioned media
7 hours ago
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue. By growing PEL cells ...
Study involving twin sisters provides clues for battling aggressive cancers
18 hours ago
Analyzing the genomes of twin 3-year-old sisters – one healthy and one with aggressive leukemia – led an international team of researchers to identify a novel molecular target that could become a way ...
Gaps exist in patient-centered quality of CRC care at VA
Feb 08, 2014
(HealthDay)—Patient-reported quality assessment measures reveal substantial gaps in patient-centered quality of colorectal cancer care, according to a study published online Feb 3 in the Journal of Clinical On ...
Synthesised sponge chemical shows promise for cancer
Feb 07, 2014
A promising compound for cancer treatment has been synthesised in a laboratory by an RMIT University researcher conducting PhD research.
Power lines don't raise risk of leukaemia in children
Feb 07, 2014
(Medical Xpress)—Children who live near overhead power lines in early life do not have a greater risk of developing childhood leukaemia, researchers from the Childhood Cancer Research Group at the University ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment